1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Multiple Sclerosis Therapeutics Market Size 2017-2028 2.1.2 Multiple Sclerosis Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028 2.2 Multiple Sclerosis Therapeutics Segment by Type 2.2.1 Beta Interferon 2.2.2 Corticosteroids 2.2.3 Monoclonal Antibodies 2.2.4 Antineoplastic Agents 2.2.5 Others 2.3 Multiple Sclerosis Therapeutics Market Size by Type 2.3.1 Multiple Sclerosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) 2.3.2 Global Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022) 2.4 Multiple Sclerosis Therapeutics Segment by Distribution Channel 2.4.1 Hospital Pharmacies 2.4.2 Retail Pharmacies 2.4.3 e-Commerce 2.5 Multiple Sclerosis Therapeutics Market Size by Distribution Channel 2.5.1 Multiple Sclerosis Therapeutics Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028) 2.5.2 Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022) 3 Multiple Sclerosis Therapeutics Market Size by Player 3.1 Multiple Sclerosis Therapeutics Market Size Market Share by Players 3.1.1 Global Multiple Sclerosis Therapeutics Revenue by Players (2020-2022) 3.1.2 Global Multiple Sclerosis Therapeutics Revenue Market Share by Players (2020-2022) 3.2 Global Multiple Sclerosis Therapeutics Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Multiple Sclerosis Therapeutics by Regions 4.1 Multiple Sclerosis Therapeutics Market Size by Regions (2017-2022) 4.2 Americas Multiple Sclerosis Therapeutics Market Size Growth (2017-2022) 4.3 APAC Multiple Sclerosis Therapeutics Market Size Growth (2017-2022) 4.4 Europe Multiple Sclerosis Therapeutics Market Size Growth (2017-2022) 4.5 Middle East & Africa Multiple Sclerosis Therapeutics Market Size Growth (2017-2022) 5 Americas 5.1 Americas Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) 5.2 Americas Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) 5.3 Americas Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Multiple Sclerosis Therapeutics Market Size by Region (2017-2022) 6.2 APAC Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) 6.3 APAC Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Multiple Sclerosis Therapeutics by Country (2017-2022) 7.2 Europe Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) 7.3 Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Multiple Sclerosis Therapeutics by Region (2017-2022) 8.2 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) 8.3 Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Multiple Sclerosis Therapeutics Market Forecast 10.1 Global Multiple Sclerosis Therapeutics Forecast by Regions (2023-2028) 10.1.1 Global Multiple Sclerosis Therapeutics Forecast by Regions (2023-2028) 10.1.2 Americas Multiple Sclerosis Therapeutics Forecast 10.1.3 APAC Multiple Sclerosis Therapeutics Forecast 10.1.4 Europe Multiple Sclerosis Therapeutics Forecast 10.1.5 Middle East & Africa Multiple Sclerosis Therapeutics Forecast 10.2 Americas Multiple Sclerosis Therapeutics Forecast by Country (2023-2028) 10.2.1 United States Multiple Sclerosis Therapeutics Market Forecast 10.2.2 Canada Multiple Sclerosis Therapeutics Market Forecast 10.2.3 Mexico Multiple Sclerosis Therapeutics Market Forecast 10.2.4 Brazil Multiple Sclerosis Therapeutics Market Forecast 10.3 APAC Multiple Sclerosis Therapeutics Forecast by Region (2023-2028) 10.3.1 China Multiple Sclerosis Therapeutics Market Forecast 10.3.2 Japan Multiple Sclerosis Therapeutics Market Forecast 10.3.3 Korea Multiple Sclerosis Therapeutics Market Forecast 10.3.4 Southeast Asia Multiple Sclerosis Therapeutics Market Forecast 10.3.5 India Multiple Sclerosis Therapeutics Market Forecast 10.3.6 Australia Multiple Sclerosis Therapeutics Market Forecast 10.4 Europe Multiple Sclerosis Therapeutics Forecast by Country (2023-2028) 10.4.1 Germany Multiple Sclerosis Therapeutics Market Forecast 10.4.2 France Multiple Sclerosis Therapeutics Market Forecast 10.4.3 UK Multiple Sclerosis Therapeutics Market Forecast 10.4.4 Italy Multiple Sclerosis Therapeutics Market Forecast 10.4.5 Russia Multiple Sclerosis Therapeutics Market Forecast 10.5 Middle East & Africa Multiple Sclerosis Therapeutics Forecast by Region (2023-2028) 10.5.1 Egypt Multiple Sclerosis Therapeutics Market Forecast 10.5.2 South Africa Multiple Sclerosis Therapeutics Market Forecast 10.5.3 Israel Multiple Sclerosis Therapeutics Market Forecast 10.5.4 Turkey Multiple Sclerosis Therapeutics Market Forecast 10.5.5 GCC Countries Multiple Sclerosis Therapeutics Market Forecast 10.6 Global Multiple Sclerosis Therapeutics Forecast by Type (2023-2028) 10.7 Global Multiple Sclerosis Therapeutics Forecast by Distribution Channel (2023-2028) 11 Key Players Analysis 11.1 Novartis 11.1.1 Novartis Company Information 11.1.2 Novartis Multiple Sclerosis Therapeutics Product Offered 11.1.3 Novartis Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.1.4 Novartis Main Business Overview 11.1.5 Novartis Latest Developments 11.2 Teva Pharmaceuticals 11.2.1 Teva Pharmaceuticals Company Information 11.2.2 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product Offered 11.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.2.4 Teva Pharmaceuticals Main Business Overview 11.2.5 Teva Pharmaceuticals Latest Developments 11.3 Sanofi Genzyme 11.3.1 Sanofi Genzyme Company Information 11.3.2 Sanofi Genzyme Multiple Sclerosis Therapeutics Product Offered 11.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.3.4 Sanofi Genzyme Main Business Overview 11.3.5 Sanofi Genzyme Latest Developments 11.4 Bayer 11.4.1 Bayer Company Information 11.4.2 Bayer Multiple Sclerosis Therapeutics Product Offered 11.4.3 Bayer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.4.4 Bayer Main Business Overview 11.4.5 Bayer Latest Developments 11.5 Pfizer 11.5.1 Pfizer Company Information 11.5.2 Pfizer Multiple Sclerosis Therapeutics Product Offered 11.5.3 Pfizer Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.5.4 Pfizer Main Business Overview 11.5.5 Pfizer Latest Developments 11.6 Biogen Idec 11.6.1 Biogen Idec Company Information 11.6.2 Biogen Idec Multiple Sclerosis Therapeutics Product Offered 11.6.3 Biogen Idec Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.6.4 Biogen Idec Main Business Overview 11.6.5 Biogen Idec Latest Developments 11.7 Merck 11.7.1 Merck Company Information 11.7.2 Merck Multiple Sclerosis Therapeutics Product Offered 11.7.3 Merck Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.7.4 Merck Main Business Overview 11.7.5 Merck Latest Developments 11.8 AbbVie 11.8.1 AbbVie Company Information 11.8.2 AbbVie Multiple Sclerosis Therapeutics Product Offered 11.8.3 AbbVie Multiple Sclerosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022) 11.8.4 AbbVie Main Business Overview 11.8.5 AbbVie Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Multiple Sclerosis Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions) Table 2. Major Players of Beta Interferon Table 3. Major Players of Corticosteroids Table 4. Major Players of Monoclonal Antibodies Table 5. Major Players of Antineoplastic Agents Table 6. Major Players of Others Table 7. Multiple Sclerosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions) Table 8. Global Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions) Table 9. Global Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022) Table 10. Multiple Sclerosis Therapeutics Market Size CAGR by Distribution Channel (2017 VS 2022 VS 2028) & ($ Millions) Table 11. Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions) Table 12. Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022) Table 13. Global Multiple Sclerosis Therapeutics Revenue by Players (2020-2022) & ($ Millions) Table 14. Global Multiple Sclerosis Therapeutics Revenue Market Share by Player (2020-2022) Table 15. Multiple Sclerosis Therapeutics Key Players Head office and Products Offered Table 16. Multiple Sclerosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Multiple Sclerosis Therapeutics Market Size by Regions 2017-2022 & ($ Millions) Table 20. Global Multiple Sclerosis Therapeutics Market Size Market Share by Regions (2017-2022) Table 21. Americas Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & ($ Millions) Table 22. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Country (2017-2022) Table 23. Americas Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions) Table 24. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022) Table 25. Americas Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions) Table 26. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022) Table 27. APAC Multiple Sclerosis Therapeutics Market Size by Region (2017-2022) & ($ Millions) Table 28. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Region (2017-2022) Table 29. APAC Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions) Table 30. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022) Table 31. APAC Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions) Table 32. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022) Table 33. Europe Multiple Sclerosis Therapeutics Market Size by Country (2017-2022) & ($ Millions) Table 34. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Country (2017-2022) Table 35. Europe Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions) Table 36. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022) Table 37. Europe Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions) Table 38. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022) Table 39. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Region (2017-2022) & ($ Millions) Table 40. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Region (2017-2022) Table 41. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Type (2017-2022) & ($ Millions) Table 42. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Type (2017-2022) Table 43. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2017-2022) & ($ Millions) Table 44. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel (2017-2022) Table 45. Key Market Drivers & Growth Opportunities of Multiple Sclerosis Therapeutics Table 46. Key Market Challenges & Risks of Multiple Sclerosis Therapeutics Table 47. Key Industry Trends of Multiple Sclerosis Therapeutics Table 48. Global Multiple Sclerosis Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions) Table 49. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Regions (2023-2028) Table 50. Global Multiple Sclerosis Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions) Table 51. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Type (2023-2028) Table 52. Global Multiple Sclerosis Therapeutics Market Size Forecast by Distribution Channel (2023-2028) & ($ Millions) Table 53. Global Multiple Sclerosis Therapeutics Market Size Market Share Forecast by Distribution Channel (2023-2028) Table 54. Novartis Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 55. Novartis Multiple Sclerosis Therapeutics Product Offered Table 56. Novartis Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 57. Novartis Main Business Table 58. Novartis Latest Developments Table 59. Teva Pharmaceuticals Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 60. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Product Offered Table 61. Teva Pharmaceuticals Main Business Table 62. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 63. Teva Pharmaceuticals Latest Developments Table 64. Sanofi Genzyme Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 65. Sanofi Genzyme Multiple Sclerosis Therapeutics Product Offered Table 66. Sanofi Genzyme Main Business Table 67. Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 68. Sanofi Genzyme Latest Developments Table 69. Bayer Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 70. Bayer Multiple Sclerosis Therapeutics Product Offered Table 71. Bayer Main Business Table 72. Bayer Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 73. Bayer Latest Developments Table 74. Pfizer Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 75. Pfizer Multiple Sclerosis Therapeutics Product Offered Table 76. Pfizer Main Business Table 77. Pfizer Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 78. Pfizer Latest Developments Table 79. Biogen Idec Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 80. Biogen Idec Multiple Sclerosis Therapeutics Product Offered Table 81. Biogen Idec Main Business Table 82. Biogen Idec Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 83. Biogen Idec Latest Developments Table 84. Merck Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 85. Merck Multiple Sclerosis Therapeutics Product Offered Table 86. Merck Main Business Table 87. Merck Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 88. Merck Latest Developments Table 89. AbbVie Details, Company Type, Multiple Sclerosis Therapeutics Area Served and Its Competitors Table 90. AbbVie Multiple Sclerosis Therapeutics Product Offered Table 91. AbbVie Main Business Table 92. AbbVie Multiple Sclerosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 93. AbbVie Latest Developments List of Figures Figure 1. Multiple Sclerosis Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Multiple Sclerosis Therapeutics Market Size Growth Rate 2017-2028 ($ Millions) Figure 6. Global Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2021 Figure 7. Multiple Sclerosis Therapeutics in Hospital Pharmacies Figure 8. Global Multiple Sclerosis Therapeutics Market: Hospital Pharmacies (2017-2022) & ($ Millions) Figure 9. Multiple Sclerosis Therapeutics in Retail Pharmacies Figure 10. Global Multiple Sclerosis Therapeutics Market: Retail Pharmacies (2017-2022) & ($ Millions) Figure 11. Multiple Sclerosis Therapeutics in e-Commerce Figure 12. Global Multiple Sclerosis Therapeutics Market: e-Commerce (2017-2022) & ($ Millions) Figure 13. Global Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021 Figure 14. Global Multiple Sclerosis Therapeutics Revenue Market Share by Player in 2021 Figure 15. Global Multiple Sclerosis Therapeutics Market Size Market Share by Regions (2017-2022) Figure 16. Americas Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions) Figure 17. APAC Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions) Figure 18. Europe Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions) Figure 19. Middle East & Africa Multiple Sclerosis Therapeutics Market Size 2017-2022 ($ Millions) Figure 20. Americas Multiple Sclerosis Therapeutics Value Market Share by Country in 2021 Figure 21. Americas Multiple Sclerosis Therapeutics Consumption Market Share by Type in 2021 Figure 22. Americas Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021 Figure 23. United States Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 24. Canada Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 25. Mexico Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 26. Brazil Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 27. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Region in 2021 Figure 28. APAC Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021 Figure 29. China Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 30. Japan Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 31. Korea Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 32. Southeast Asia Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 33. India Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 34. Australia Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 35. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Country in 2021 Figure 36. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2021 Figure 37. Europe Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021 Figure 38. Germany Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 39. France Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 40. UK Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 41. Italy Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 42. Russia Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 43. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Region in 2021 Figure 44. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Type in 2021 Figure 45. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Market Share by Distribution Channel in 2021 Figure 46. Egypt Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 47. South Africa Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 48. Israel Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 49. Turkey Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 50. GCC Country Multiple Sclerosis Therapeutics Market Size Growth 2017-2022 ($ Millions) Figure 51. Americas Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 52. APAC Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 53. Europe Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 54. Middle East & Africa Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 55. United States Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 56. Canada Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 57. Mexico Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 58. Brazil Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 59. China Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 60. Japan Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 61. Korea Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 62. Southeast Asia Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 63. India Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 64. Australia Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 65. Germany Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 66. France Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 67. UK Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 68. Italy Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 69. Russia Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 70. Spain Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 71. Egypt Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 72. South Africa Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 73. Israel Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 74. Turkey Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions) Figure 75. GCC Countries Multiple Sclerosis Therapeutics Market Size 2023-2028 ($ Millions)